X

Vous n'êtes pas connecté

Maroc Maroc - NEWS.MEDICAL.NET - A la Une - 12/07/2024 17:05

Study reveals potential cognitive benefits of antidiabetic drugs

Investigators analyzing the potential cognitive effects of antidiabetic medications in records of more than 1.5 million patients with type 2 diabetes mellitus (T2DM) found risks of dementia and Alzheimer's disease (AD) were significantly lower in patients treated with metformin and sodium glucose co-transporter-2 inhibitors (SGLT-2i) compared to other antidiabetic drugs.

Articles similaires

New diabetes treatment may help patients improve well-being

knowridge.com - 01:07

Living with type 2 diabetes can be challenging. People need to manage their diet, take medications, and monitor their blood sugar regularly. This...

New diabetes treatment may help patients improve well-being

knowridge.com - 01:07

Living with type 2 diabetes can be challenging. People need to manage their diet, take medications, and monitor their blood sugar regularly. This...

Sorry! Image not available at this time

Metformin Vs Ozempic: Which Diabetes Drug Is Better For Blood Sugar?

wn.com - 28/Mar 12:57

Metformin is usually the first-choice for the treatment of type 2 diabetes. This drug mainly works by lowering glucose production in the liver. It...

Sorry! Image not available at this time

How to distinguish dementia from normal aging

wn.com - 25/Mar 22:02

Researchers identify strategy to slow memory loss in Alzheimer’s New York researchers have discovered a way to slow memory loss and boost learning...

Sorry! Image not available at this time

Type 1 diabetes associated with higher risk of dementia, reveals study

zeenews.india.com - 23/Mar 22:04

The researchers estimated that people with type 1 diabetes were nearly three times as likely to develop dementia as people without diabetes.

Sorry! Image not available at this time

Checkpoint Inhibitors Competitive Landscape & Pipeline 2026: Emerging Therapies, ROA, Molecules, Companies and Future Outlook

wn.com - 27/Mar 19:42

DelveInsight’s, “Checkpoint Inhibitors Competitive landscape 2026” report provides comprehensive insights about 50+ companies and...

Sorry! Image not available at this time

Common Diabetes Drug Metformin Works By Acting On Brain: Study

wn.com - 26/Mar 13:27

While diabetes medications are not considered as targeting the brain, the study, published in the journal Science Advances, shows that metformin has...

Popular weight loss and diabetes drugs reduces depression, anxiety, and addiction risk

knowridge.com - 28/Mar 10:34

A new international study has found that medications used to treat diabetes and obesity may also help improve mental health. The research focused on a...

Sorry! Image not available at this time

SYK Inhibitors Clinical Trial Pipeline Shows Potential with Active Contributions from 10+ Key Companies | DelveInsight

wn.com - 26/Mar 22:29

DelveInsight’s, “Spleen Tyrosine Kinase (SYK) Inhibitors Pipeline Insight, 2026” report provides comprehensive insights about 10+...

Can Cholesterol Drugs Stop First Heart Attacks in Diabetes?

medindia.net - 30/Mar 18:35

Earlier use of cholesterol lowring drug evolocumab may reduce heart attack and stroke risk in high-risk diabetes patients without known heart...